Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1999
07/27/1999US5929099 1-h-benzimidazole derivatives used as anticarcinogenic, antitumor and antileukemia agents
07/27/1999US5929096 Method for treating atopic dermatitis and contact dermatitis
07/27/1999US5929095 Method of inhibiting secretory effects caused by Cholera
07/27/1999US5929092 Lipophilic benzothiophenes for treating estrogen deficiency
07/27/1999US5929091 Method of lowering plasma levels of lipoprotein(a)
07/27/1999US5929089 Antiserotonine agent
07/27/1999US5929088 Treatment of epilepsy, fainting, neurodegenerative disorders, anxiety, pain, panic attacks
07/27/1999US5929086 Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
07/27/1999US5929084 Treating myasthenia by inhibiting cholinesterase comprising administering huperazine a derivative to the patient
07/27/1999US5929081 Method for treating diseases mediated by cellular proliferation in response to PDGF, EGF, FGF and VEGF
07/27/1999US5929080 Administering phenylaminoquinazoline derivative
07/27/1999US5929078 Antiserotonine agent
07/27/1999US5929075 Apolipoprotein-B synthesis inhibitors
07/27/1999US5929074 Vsodilator, antiallergic and antiplatelet agents
07/27/1999US5929072 Treatment of central nervous system disorders
07/27/1999US5929070 Method for treating migraine pain with olanzapine
07/27/1999US5929069 Compounds activating pharmacological effects of retinoids
07/27/1999US5929067 N-acylating amine derivative of caprolactam compound with a carboxylic acid or derivatives to form amide derivative of caprolactam compound
07/27/1999US5929066 Administering to a patient suffering from non-insulin depentednt (type ii) diabetes and effective amount of synthetic chromic tripicolinate and biotine
07/27/1999US5929065 Adminsitering a patient suffering from sleep disorder a hypnotically effective amount of 4,5,6,7-tetrahydroisoxaxole(5,4-c)pyridine-3-ol(thip)
07/27/1999US5929063 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
07/27/1999US5929062 Combination of one or more oxysterols and a suitable carrier; anticholesterol agents
07/27/1999US5929061 Method for treating vascular headaches
07/27/1999US5929060 Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
07/27/1999US5929059 Administering for treatment or prophylaxis of cytotoxic agent-induced nausea and vomiting in a human or animal subject
07/27/1999US5929058 Treatment agents and methods for treating type II diabetes and symptoms of type II diabetes
07/27/1999US5929057 Pharmaceutical composition for the treatment of leukemia containing 9-cis-retinoic acid-α-tocopherol ester
07/27/1999US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics
07/27/1999US5929055 Tetracycline
07/27/1999US5929054 Use of NK-1 receptor antagonists for treating sexual dysfunctions
07/27/1999US5929050 Chondroitin sulfate composition and method for wound treatment
07/27/1999US5929048 Treatment of conditions and disease
07/27/1999US5929047 Anti-viral agent prepared by basic and acidic extraction of mangraves
07/27/1999US5929046 Pyrimidine and purine derivatives and their use in treating tumour cells
07/27/1999US5929045 Screening for bactericides
07/27/1999US5929040 Method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
07/27/1999US5929039 Method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
07/27/1999US5929038 Administering iridoid compounds
07/27/1999US5928910 Antifungal substances BE-49385 and process for their production
07/27/1999US5928885 Includes one detectable antibody against 80 kilodalton form of calcium-activated neutral proteinase, another detectable antibody against other isoforms, standard serial dilutions of proteinase isoforms for standard curve
07/27/1999US5928668 Method for dry blend compression of medicaments
07/27/1999US5928666 Crystalline form of estradiol and pharmaceutical formulations comprising same
07/27/1999US5928645 Extract containing berberine and a flavonoid
07/27/1999US5928641 Having binding specificity for crossreactive epitopes shared by endoglin expressed on human vascular endothelial cells and endoglin expressed on murine vascular endothelial cells
07/27/1999US5928639 Immunotherapy of cancer with allogeneic lymphocytes
07/27/1999US5928636 Injecting synergistic mixture to treat herpes, hepatitis, papilloma and human t-cell leukemia/lymphoma viruses; administering as bactericide, parasiticide, and/or antiprotozoa agent
07/27/1999US5928633 Material for elimination or detoxification of super antigens
07/27/1999US5928632 Oil in water emulsion comprising gelled mineral oil as primary emollient and emulsion stabilizer of a carbomer or copolymer of unsaturated acid or anhydride and long chain alkyl(meth)acrylate or acrylic acid homopolymer; feel deposit
07/27/1999US5927283 Treating diseases involving oxygen deficiency, in wound healing, and in restoring oxygen affinity of stored blood.
07/27/1999CA2215327C Formulations for lipophilic compounds
07/27/1999CA2181175C Dihydro pyrazolopyrroles
07/27/1999CA2173444C Cosmetic composition comprising a hydrochalcone and optionally retinol or a derivative thereof
07/27/1999CA2170700C Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
07/27/1999CA2170622C Oral formulations of an antifungal
07/27/1999CA2166721C Bicyclic tetrahydro pyrazolopyridines
07/27/1999CA2164804C Nk-1 receptor antagonists for the treatment of neuronal injury and stroke
07/27/1999CA2158853C New anti viral compounds
07/27/1999CA2157475C Method for treating emotional or mental illness and emotional or mental illness concomitant with seizures
07/27/1999CA2155837C Benzopyrans as potassium channel openers
07/27/1999CA2025663C Indole derivatives
07/27/1999CA2016504C Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
07/27/1999CA2009074C Improvements in and relating to guanidine derivatives
07/22/1999WO1999036562A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
07/22/1999WO1999036553A2 Regulation of biological events using multimeric chimeric proteins
07/22/1999WO1999036544A2 Neisseria meningitidis antigens
07/22/1999WO1999036531A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
07/22/1999WO1999036519A1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
07/22/1999WO1999036518A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4
07/22/1999WO1999036514A1 Methods and compositions for gene delivery
07/22/1999WO1999036507A1 Vaccine compositions and methods of modulating immune responses
07/22/1999WO1999036443A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
07/22/1999WO1999036436A1 FATTY ACID SYNTHASE mRNA BINDING PROTEIN
07/22/1999WO1999036428A1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same
07/22/1999WO1999036426A1 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE)
07/22/1999WO1999036425A1 Platelet adp receptor inhibitors
07/22/1999WO1999036424A1 Piperazino derivatives as neurokinin antagonists
07/22/1999WO1999036423A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/22/1999WO1999036422A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
07/22/1999WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
07/22/1999WO1999036420A1 Thiophene nitrone compounds
07/22/1999WO1999036418A1 Substituted bicyclic lactones
07/22/1999WO1999036417A1 SUBSTITUTED β,η-ANELLATED LACTONES
07/22/1999WO1999036416A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES
07/22/1999WO1999036415A1 Thioether furan nitrone compounds
07/22/1999WO1999036413A1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol
07/22/1999WO1999036410A1 Triazine antiviral compounds
07/22/1999WO1999036409A1 Metabolically inert anti-inflammatory and anti-tumor antifolates
07/22/1999WO1999036408A1 Novel pyrimidine derivatives
07/22/1999WO1999036407A1 Novel allylthiopyridazine derivatives and process for preparing the same
07/22/1999WO1999036406A1 Antivirals
07/22/1999WO1999036404A1 Bisulfate salt of hiv protease inhibitor
07/22/1999WO1999036398A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
07/22/1999WO1999036396A1 Triazepinones, process for their preparation and their therapeutic application
07/22/1999WO1999036393A1 INHIBITORS OF α4 MEDIATED CELL ADHESION
07/22/1999WO1999036392A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
07/22/1999WO1999036384A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
07/22/1999WO1999036383A1 Substances capable of inducing apoptosis
07/22/1999WO1999036100A2 Polymeric carrier
07/22/1999WO1999036098A1 Antibacterial composition for topical administration containing antibiotics
07/22/1999WO1999036096A1 Pharmaceutical formulations and processes for their preparation